SCHEMBL3405568

SCHEMBL3405568

CC(C)C(CC(=O)NC(CC(=O)N1CCC(c2cccs2)(N(C)C)CC1)c1ccccc1)c1c[nH]c2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.36
MGAM O43451 4/20 0.36
SI P14410 4/20 0.36
MGAM2 Q2M2H8 4/20 0.36
SSTR2 P30874 2/20 0.35
MAPT P10636 4/20 0.34
NOD2 Q9HC29 1/20 0.34
SNCA P37840 1/20 0.34
OPRM1 P35372 2/20 0.33
OPRL1 P41146 2/20 0.33
KMT2A Q03164 4/20 0.33
MEN1 O00255 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPK1 P28482 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
PKM P14618 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TP53 P04637 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407495 0.93 GAA (0.37) GAAMGAMSIMGAM2SSTR2
SCHEMBL3409409 0.87 GAA (0.37) GAAMGAMSIMGAM2SSTR2
SCHEMBL3408073 0.83 MGAM (0.38) GAAMGAMSIMGAM2SSTR2
SCHEMBL3401727 0.82 OPRM1 (0.42) GAAMAPTSNCAOPRM1OPRL1
SCHEMBL3405014 0.81 GAA (0.37) GAAMGAMSIMGAM2SSTR2
SCHEMBL3403667 0.79 ACHE (0.36) GAASNCAOPRM1OPRL1NPSR1
SCHEMBL4091868 0.77 PKM (0.38) GAAMGAMSIMGAM2MAPT
SCHEMBL3407998 0.76 OPRM1 (0.40) GAAMGAMSIMGAM2SSTR2
SCHEMBL3408786 0.76 OPRM1 (0.35) GAASNCAOPRM1OPRL1KMT2A
SCHEMBL3407477 0.75 OPRL1 (0.42) MAPTOPRM1OPRL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US claimed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP claimed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US claimed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US claimed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP disclosed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO disclosed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215828-A1 Substituted indole derivatives IDO1, IDO2, TPH1 GAA 2847/4885MGAM 2733/4885SI 126/4885
US-20130116283-A1 Substituted indole derivatives IDO1, IDO2, TPH1 GAA 2847/4885MGAM 2733/4885SI 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.